NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Hormone

Oral

12.1 Mechanism of Action COCs lower the risk of becoming pregnant primarily by suppressing ovulation.

a progestin

and ethinyl estradiol

an estrogen

8.8 )

Contraindications

• if over age 35 [see Boxed Warning
• and Warnings and Precautions (5.1) ] o Have deep vein thrombosis or pulmonary embolism
• subacute bacterial endocarditis with valvular disease
• or history of
• breast cancer

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) if a thrombotic event occurs
Although the use of COCs increases the risk of venous thromboembolism, pregnancy increases the risk of venous thromboembolism as much or more than the use of COCs
The risk of venous thromboembolism in women using COCs is 3 to 9 per 10,000 woman-years
The excess risk is highest during the first year of use of a COC

10 documented side effects by frequency

Nausea

>10%

Headache

>10%

Drug Not Working

1-10%

Fatigue

1-10%

Anxiety

1-10%

Dizziness

1-10%

Diarrhea

1-10%

Depression

1-10%

Vomiting

0.1-1%

Abdominal Pain

0.1-1%

No community discussions found for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE yet.

0 available comparisons

No comparisons yet.

Dosage Forms

Tablet

Route

Oral